MedPath

Diaphragm Ultrasound in Neuromuscular Disorders

Conditions
Muscular Dystrophies
Registration Number
NCT04045158
Lead Sponsor
Centre d'Investigation Clinique et Technologique 805
Brief Summary

Muscular dystrophies are neurologic disease with higher morbidity and mortality. Cardiac function and respiratory muscles can be affected, in addition with skeletal muscle deficiency . Lung function is classically assessed with functionnal pulmonary tests (FPT) . Ultrasound recently emerged as a non-invasive tool to assess diaphragm function.

The aims of the study are:

* to provide the spectrum of diaphragm ultrasound in patients with muscular dystrophies

* to assess the correlation between diaphragm ultrasound and FPT

* to assess the correlation between diaphragm ultrasound and cardiac function

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Duchenne muscular dystrophy,
  • Becker muscular dystrophy,
  • LGMD,
  • myotonic dystrophy type 1 and type 2,
  • metabolic myopathy,
  • mitochondrial myopathy,
  • FSHD1 and 2,
  • myasthenia
Exclusion Criteria
  • history of cardiac surgery
  • history of thoracic surgery
  • brain traumatism

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
diaphragm ultrasound motion1 year

using echography

Secondary Outcome Measures
NameTimeMethod
correlation between diaphragm motion (mm) and forced vital capacity(ml)1 year

using echography and FPT

correlation between diaphragm motion (mm) and inspiratory capacity (ml)1 year

using echography and FPT

diaphragm thickness (mm)1 year

using echography

correlation between diaphargm thickness and maximal inspiratory pressure (cmH20)1 year

using echography and FPT

Trial Locations

Locations (1)

Hopital Raymond Poincare

🇫🇷

Garches, France

© Copyright 2025. All Rights Reserved by MedPath